What is palliative care and what does it mean for me as a cancer patient?

Posted by  | caregiving, treatment

According to experts at the Johns Hopkins Kimmel Cancer Center, palliative care is “ease without curing.” Its focus is improving the quality of life for seriously ill patients, helping you to carry on with your daily life while you undergo treatment, and helping you tolerate medical treatments. Palliative care includes three key approaches: • pain(...)

When and where should I apply for Social Security disability?

Posted by  | caregiving, Uncategorized

If you’re a cancer patient, you should apply for disability benefits as soon as you become disabled, according to social workers at the Johns Hopkins Kimmel Cancer Center. .  It can take months to process your application for either Social Security Disability or Supplemental Security Income. The Social Security Administration's eligibility screening tool is available online. If you(...)

Does your income qualify for Social Security disability? What cancer patients need to know

Posted by  | caregiving, treatment, Uncategorized

Supplemental Security Income guidelines are set by the federal government for all 50 states, according to social workers at the Johns Hopkins Kimmel Cancer Center. Income may include your wages, Social Security benefit payments, and pensions. It also includes resources like real estate, bank accounts, cash, stocks and bonds, and food and shelter. Your total monthly income,(...)

Do you qualify for Social Security disability as a cancer patient? 5 tests

Posted by  | caregiving, Issues & Perspectives, treatment, Uncategorized

Social Security pays benefits for a medical condition that is expected to last for at least a year, or may result in death.  Supplemental Security Income (SSI) supports the aged, blind or disabled who have little or no income, providing cash for basics like food, clothing and shelter. According to social workers at the Johns Hopkins(...)

‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle

‘Individualized’ Immune Cell Engineering Therapy for Cancer Clears First FDA Hurdle

Posted by  | precision medicine

*Update Aug. 30, 2017 - The FDA has approved the CAR-T therapy tisagenlecleucel for certain leukemia patients. News of an FDA advisory committee that has reviewed one pharmaceutical company's approach to engineering a cancer patient's own T-cells, the so-called soldiers of the immune system, and injecting them back into patients with astounding success has prompted questions(...)

Should all prostate cancers be treated?

Posted by  | treatment

“Prostate cancer mortality has been declining since prostate cancer screening started in 1995,” says William G. Nelson, M.D., Ph.D., director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. “There’s no question that it works. The problem is diagnosing these cancers in men who aren’t threatened by the disease and then pursuing treatment." "When(...)